If you only glance at the share price, you might think the Hims & Hers Health ($HIMS) story has lost its spark. The stock has declined by more than......

Hims & Hers Health’s ($HIMS) shares continued to plunge on Thursday despite the consumer telehealth company launching a new “affordable” healthcare......

In a report released on November 4, Craig Hettenbach from Morgan Stanley maintained a Hold rating on Hims & Hers Health, with a price target of $40......

Hims & Hers Health ($HIMS) stock has been a wild ride lately, as investors struggle to decide whether it’s the future of consumer health or just a ......

Hims & Hers Health, Inc. (($HIMS)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for Hims & ......

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS – Research Report), BioNTech SE (BNTX – ......

In a report released today, Justin Patterson from KeyBanc maintained a Hold rating on Hims & Hers Health. The company’s shares closed yesterday at ......

Shares of Hims & Hers Health ($HIMS) rallied in pre-market hours on Tuesday after management said it’s in discussions with Novo Nordisk ($NVO) to o......

The share price has been volatile. ...

Telehealth platform Hims & Hers Health ($HIMS) is scheduled to announce its third-quarter earnings on Monday, November 3, and the options market is......